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Abstract
The introduction of transgenes into Plasmodium falciparum, a highly virulent human malaria parasite, has been conducted
either by single crossover recombination or by using episomal plasmids. However, these techniques remain insufficient
because of the low transfection efficiency and the low frequency of recombination. To improve the genetic manipulation of
P. falciparum, we developed the centromere plasmid as a new genetic tool. First, we attempted to clone all of the predicted
centromeres from P. falciparum into E. coli cells but failed because of the high A/T contents of these sequences. To
overcome this difficulty, we identified the common sequence features of the centromere of Plasmodium spp. and designed
a small centromere that retained those features. The centromere plasmid constructed with the small centromere sequence,
pFCEN, segregated into daughter parasites with approximately 99% efficiency, resulting in the stable maintenance of this
plasmid in P. falciparum even in the absence of drug selection. This result demonstrated that the small centromere
sequence harboured in pFCEN could function as an actual centromere in P. falciparum. In addition, transgenic parasites
were more rapidly generated when using pFCEN than when using the control plasmid, which did not contain the
centromere sequence. Furthermore, in contrast to the control plasmid, pFCEN did not form concatemers and, thus, was
maintained as a single copy over multiple cell divisions. These unique properties of the pFCEN plasmid will solve the current
technical limitations of the genetic manipulation of P. falciparum, and thus, this plasmid will become a standard genetic tool
for the study of this parasite.
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Introduction
Plasmodium falciparum causes the most severe form of malaria in
humans, and infection with this parasite is responsible for
considerable morbidity and mortality worldwide. Despite intense
research efforts, no effective vaccines are currently available to
prevent malaria, and the global spread of drug-resistant parasites
has not been halted [1].
In the post-genomic era, the genetic manipulation of P.
falciparum is an essential technology to confront the serious
problems of malaria [2,3]. In particular, the ability to introduce
transgenes is a fundamental technique in the genetic manipulation
in P. falciparum; currently, transgenes are introduced by integration
into the parasite genome by single crossover recombination [4].
This approach is widely used but still involves technical limitations
because single crossover events rarely occur; it usually takes several
months (e.g., 2,6 months) to generate stable transgenic parasites.
In addition, these transgenic parasites often lose the integrated
transgenes during long-term cultivation as the result of additional
recombination and, thus, revert to wild-type parasites. As an
alternative approach, an episomal plasmid can be used for the
introduction of a transgene [2], but such plasmids readily form
large concatemers during replication, resulting in an increase
number of copies of the plasmid [5,6]. This increase in the copy
number of the transgene results in the overproduction of the
corresponding transcript and protein product, preventing an
accurate analysis of the function of the gene. Episomal plasmids
also unevenly segregate into daughter parasites during cell
division, and thus, the parasites readily lose the plasmid unless
selective pressure is maintained. These technical problems hinder
the progress of the molecular analysis of P. falciparum; thus, a new
genetic tool is required.
Through its physical association with the kinetochore, the
centromere is the essential genomic region for the fidelity of
chromosome segregation during nuclear division. Centromere-
associated functions include sister chromatid association and
separation, microtubule attachment, chromosomal movement,
and the establishment of heterochromatin and mitotic check-point
control [7,8,9]. In P. falciparum, the highly A/T-rich regions of
each chromosome have been predicted to be centromeres [10,11].
However, there has been no experimental evidence for their
function, and thus, it has remained unclear whether these regions
function as actual centromeres. Previously, we cloned the putative
centromere from chromosome 5 of the rodent malaria parasite P.
berghei based on the rodent malaria gene synteny map [12]. We
showed that the plasmid harbouring the cloned centromere, called
the centromere plasmid, segregated with more than 99.9%
efficiency into the daughter cells during cell division, demonstrat-
ing that the cloned putative centromere functioned as an actual
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evidence of the identity of the centromere of Plasmodium spp.
This efficient segregation of the centromere plasmid resulted in
its stable maintenance in the parasites throughout their life cycle.
In addition, the centromere plasmid was maintained as a single
copy without any integration over multiple rounds of nuclear
division. These unique properties, such as the efficient segregation,
stable maintenance, and a low copy number, suggest that the
centromere plasmid could be a useful genetic tool for the study of
P. falciparum. In this study, we anticipated that these unique
properties of the centromere plasmid could solve some current
technical limitations of the genetic manipulation of P. falciparum,
such as the low transfection efficiency, the increase of copy
number of the transgene, and the uneven segregation of the
introduced plasmid, and thus, we attempted to develop such a
plasmid for this parasite. We first identified the common feature of
the centromeres of Plasmodium spp., and then we constructed the
centromere plasmid, pFCEN, using a centromere sequence that
retained the common features. The pFCEN plasmid segregated
with greater than 99% efficiency into daughter cells, showing that
the incorporated centromere functioned properly as an actual
centromere during cell division. We further dramatically short-
ened the period for the generation of transgenic parasites by using
pFCEN. Based on these properties of pFCEN, we discuss how the
centromere plasmid improves the current genetic modification
technology of P. falciparum.
Results
Sequence analysis of the centromere of Plasmodium spp.
and construction of the P. falciparum centromere
plasmid
The centromere of P. falciparum has been predicted to be a 2–
3 kb AT-rich region (.96%) with no protein-coding potential in
chromosomes 1 through 9, 12 and 13 [10,11,13]. As a result of the
sequence analysis of the P. falciparum genome, we had previously
identified two additional putative centromeres in chromosomes 11
and 14 ([12] Figure 1 and Table S1). According to these
predictions, in the present study, we first amplified all of the
putative centromeres. Several centromeres were cloned into the
TA cloning vector (data not shown), but the centromere plasmids,
including those cloned centromeres, could not be generated
because of their instability in E. coli cells. The instability of the
resulting centromere plasmids was likely caused by their high A/T
contents.
To generate a stable centromere plasmid in E. coli cells, we next
attempted to shorten the centromere. To this end, we analysed in
detail the sequence features of the centromeres of Plasmodium spp.
using the Dotlet program. Briefly, we predicted the centromeres of
P. vivax and P. berghei and obtained sequence information for the
centromere of P. yoelii from GenBank [14]. The subsequent dot
matrix analysis of each centromere was performed using the
centromeres from P. falciparum, P. vivax, P. yoelii, and P. berghei.A s
shown in Figure 1 and Table S1, except for two centromeres in P.
vivax, all of the centromeres consisted of non-repetitive and
repetitive regions. We did not identify the repetitive regions in the
two abovementioned excepted centromeres, but these regions
might have been missed due to low sequence complexities during
the automatic sequence assembly in the sequencing of the genome.
In addition, the repetitive regions appeared to localise to one end
of the centromeres. Together with the high A/T contents, those
two aspects were speculated to be common sequence features of
the centromeres of Plasmodium spp.
We further compared the sequences of each centromere using
the Dotlet and BLAST2 programs, but no conserved sequence
motifs were found. The dot matrix analyses of the centromeres
from chromosome 5 of the two rodent malaria parasites, P. berghei
and P. yoelii, showed that their non-repetitive regions shared
sequence similarities (Figure S1); furthermore, the lengths of the
repetitive regions were roughly conserved (Figure 1 and Table S1).
Similar results were obtained from the dot matrix analysis of the
centromeres from chromosome 13 of the two rodent malaria
parasites (Figure. S1). Interestingly, the non-repetitive regions of
both centromeres of P. berghei were shorter than those of P. yoelii
(Figure. S1). This result suggested that the lengths of the non-
repetitive regions of the centromere were not conserved during
evolution, suggesting that the truncation of this region does not
affect the function of the centromere in Plasmodium spp.
Based on the sequence analyses of the centromeres of Plasmodium
spp., we focused on the centromere from chromosome 5 of P.
falciparum (Figure 2A and B) and then designed a set of primers to
truncate the non-repetitive regions on both ends, as shown in
Figure 2C. The amplified small centromere (1467 bp), pfcen5-1.5,
consisted of the original repetitive region and a truncated non-
repetitive region (Figure 2C); the repetitive region was placed at
one end in pfcen5-1.5. The amplified pfcen5-1.5 sequence was
cloned into a plasmid containing the human dihydrofolate
reductase (hdhfr) gene and the green fluorescent protein (gfp) gene,
which served as a drug-selectable marker and a fluorescence
marker, respectively (Figure 2D). The transcription of the hdhfr and
gfp genes was controlled under the dual-oriented promoter of
elongation factor a of P. berghei. The resulting centromere plasmid
harbouring pfcen5-1.5, named pFCEN, was stably maintained in E.
coli cells, as expected. Furthermore, the sequence analysis of the
recovered plasmid showed that there were no mutations or
deletions over its entire sequence (data not shown).
P. falciparum can be transfected with high efficiency
using pFCEN
The constructed pFCEN plasmid was introduced into the wild-
type P. falciparum 3D7 strain using DNA-preloaded red blood cells
(RBCs), and the parasitemia of the transfected parasites was then
monitored every 48 hours. Treatment with pyrimethamine for
screening the parasites that contained pFCEN was initiated 4 days
after the transfection. The transfected parasite culture was diluted
2-folds with complete medium containing fresh RBCs every 10
days to compensate the loss of old RBCs. In this study, we used
pCon as the negative control plasmid; this plasmid includes both
the hdhfr and gfp genes but not the centromere (the pfcen5-1.5
sequence). As shown in Figure 3, the parasites transfected with
pFCEN emerged more rapidly than the control parasites carrying
pCon. The parasitemia of the parasites transfected with pFCEN
was approximately 2.8% at 20 days after transfection, whereas that
of the control parasites was only 0.08% at the same time interval.
It ultimately took 28 days for the parasitemia of the control
parasites to reach 2.9%. Because the multiplication rate (every
48 hours) of the parasites carrying pCon was estimated to be 2.9
based on the parasitemia, we estimated that the transfection
efficiency of pFCEN was approximately 70-fold higher than that
of pCon.
The multiplication rate of the parasites carrying pFCEN was
estimated to be 3.7 in this transfection experiment. Thus, the
relationship between the parasitemia of each parasite at 20 days
was represented by following equation:
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where Pcen and Pcon are the percentages of the parasitemia of
parasites carrying pFCEN and pCon at 20 days after transfection,
respectively, and I and I9 are the presumed initial number of the
parasites transfected with those plasmids. According to this
equation, the I/I9 ratio was determined to be approximately 3
using the observed Pcen and Pcon values, suggesting that pFCEN
was introduced into the parasites with an efficiency similar to that
of pCon. Therefore, these results suggest that the high transfection
efficiency of the pFCEN plasmid was due to the improved
segregation efficiency of this plasmid (discussed below), resulting in
the rapid generation of transgenic parasites.
The pFCEN plasmid segregates efficiently as the result of
the function of pfcen5-1.5 during nuclear division
During the schizogony of P. falciparum, a single parasite
undergoes 4 to 5 rounds of DNA synthesis, mitosis, and nuclear
division to produce a syncytial schizont with 16 to 22 nuclei [15].
In this process, the replicated chromosomes segregate evenly into
newly generated nuclei, which result in daughter parasites,
merozoites. In contrast to this even segregation, episomal plasmids
that are introduced by transfection are unevenly divided into the
Figure 1. Centromere of Plasmodium spp. Schematic drawings of the centromeres of Plasmodium spp., including P. falciparum, P. vivax, P.
berghei, and P. yoelii are shown. Each centromere of P. falciparum, P. berghei and P. yoelii is named after the corresponding chromosome number, and
the centromeres of P. vivax are named after the corresponding contig numbers. Triangles indicate the repetitive sequence elements that were
identified using the Tandem Repeats Finder program. The numbers in parenthesis show the repeat counts for each repetitive region. Other sequence
information is summarised in Table S1.
doi:10.1371/journal.pone.0033326.g001
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plasmids are rapidly lost from parasites in the absence of drug
selection, leading to a growth disadvantage of the transgenic
parasites in the presence of selection. As shown in Figure. S2, the
parasites transfected with the pCon plasmid grew more slowly in
the presence of pyrimethamine than in its absence (Method S1). In
contrast, the growth of the parasites carrying the pFCEN plasmid
was faster than that of the control parasite carrying pCon in the
presence of this drug (Fig.S2, blue lines). This result suggests that
pFCEN segregated more efficiently than pCon during nuclear
division.
To investigate the segregation efficiency of pFCEN in detail, we
next examined its stability in parasites without selective pressure
using the following assay: transfected parasites were first
maintained for 7 days in the presence of the drug to ensure that
all of them retained the plasmid; then the drug was removed.
Subsequently, the parasites were continuously cultured in the
absence of the drug, and their GFP expression was monitored to
determine whether the parasites retained the plasmid. This
analysis showed that the GFP expression was more stably
maintained in the parasites transfected with the pFCEN plasmid
than in those transfected with the pCon plasmid (Figure 4A and
B). Approximately 80% of the parasites carrying pFCEN still
expressed GFP, whereas less than 10% of the parasites carrying
pCon were GFP positive 8 days after the removal of the
pyrimethamine (Figure 4B). The calculated segregation efficiencies
of the pFCEN and pCon plasmids were 99.160.2% and
88.660.4% per nuclear division, respectively, based on the
assumption that 5 nuclear divisions occur during schizogony.
This result clearly showed that the pfcen5-1.5 sequence conferred
the improved segregation to the plasmid during schizogony,
indicating that pfcen5-1.5 functioned as a centromere in P.
falciparum.
The pFCEN plasmid is stably maintained as a single copy
without any integration over multiple rounds of cell
divisions
Interestingly, the fluorescence intensity of GFP in the parasites
carrying pFCEN was significantly weaker than that in the control
Figure 2. Sequence Properties of the Centromere from Chromosome 5 of P. falciparum and the Plasmid Map of pFCEN. (A) The
sequence analysis of the centromere of chromosome 5 of P. falciparum was performed using Artemis 11 with regard to its length and A/T content.
The line at the bottom indicates the centromere, and its length and A/T content are 2170 bp and 97.5%, respectively. The genomic sequence data of
chromosome 5 were obtained from PlasmoDB (http://plasmodb.org/). (B) The repetitive region in the centromere of chromosome 5 was identified by
the dot matrix analysis using the Dotlet program. The inset box indicates the repetitive region in this centromere. (C) The centromere of chromosome
5 is schematically shown and named pfcen5 in this Figure. The line on the top indicates the repetitive and non-repetitive regions. The triangle
indicates the 19 bp of the repeat sequence motif, and the number in parentheses is the number of repeats within the repetitive region. The
schematic drawing of pfcen5-1.5 also is shown. The numbers at the bottom are based on the sequence number of pfcen5 and correspond to the
beginning and the end of pfcen5-1.5. (D) The pFCEN plasmid is 8018 bp, and pfcen5-1.5 is placed downstream of the 39 UTR of the dhfr-ts gene of P.
berghei.
doi:10.1371/journal.pone.0033326.g002
Figure 3. The Growth of the Transgenic Parasite after
Transfection with pFCEN. The transfection of the parasite with
pFCEN (red line) and pCon (blue line) were performed as described in
the Materials and Methods. After 48 hours, the drug screening of the
transgenic parasites was initiated by supplementing the culture
medium with pyrimethamine. The parasitemia of the transgenic
parasites was monitored every 48 hours after transfection. The
transfection experiments for each plasmid were performed in triplicate.
doi:10.1371/journal.pone.0033326.g003
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expression levels of GFP were different between the two types of
parasites, although the transcription of the gfp gene was controlled
by a promoter common to both plasmids. We therefore speculated
that the copy numbers of these two plasmids differed, resulting in
the observed difference in the GFP intensities.
To determine the copy number of the pFCEN and pCon
plasmids, we conducted a Southern analysis of the genomic DNA
isolated from the parasites carrying each plasmid by simulta-
neously using two DNA probes, one for the gfp gene and one for
the pfsir2A gene. In this analysis, the pfsir2A gene was used as an
internal standard, and the copy number of each plasmid was
estimated based on the comparison of the intensities of the signals
from the gfp and pfsir2A genes. As shown in Figure 5A, the signal of
pCon was significantly stronger than that of pFCEN. The copy
numbers of pFCEN and pCon were calculated to be 1.160.1 and
10.261.4, respectively, indicating that pfcen5-1.5 suppressed the
increase in the copy number of the plasmid.
The Southern analysis of pFCEN showed that the signal for this
plasmid was detected at its expected size when the isolated
genomic DNA was digested with restriction enzymes that cleaved
the pFCEN once (see Materials and Methods and Figure 5A). If
pFCEN was integrated into the parasite genome by single or
double crossover, the signals would be detected at sizes different
from that of the plasmids. Therefore, pFCEN would not be
integrated into the genome of the parasites during replication,
implying that it would be maintained in an episomal form in the
parasite over multiple rounds of cell division.
Because pFCEN did not have any sequence homology with the
genomic sequence of P. falciparum, except for the centromere
(pfcen5-1.5), it would not be expected to be integrated. To exclude
the possibility of integration, we next investigated whether the
centromere plasmid including a DNA sequence from P. falciparum
could be integrated during long-term cultivation. To this end, we
generated another centromere plasmid, pFCENv2 (Figure. S3A,
Method S2). The pFCENv2 plasmid contains the 59-UTR of the
calmodulin gene (1011 bp) and the 39-UTRs of the heat shock
protein (834 bp) and histidine-rich protein 2 (590 bp) genes of P.
falciparum and these DNA sequences could be utilized for the single
crossover recombination with the genome of P. falciparum.W e
cultured the transgenic parasites carrying pFCENv2 for 2 months
in the presence of the drug and then used their genomic DNA for
Southern analysis. As shown in Figure. S3B, the signals of
pFCENv2 were detected at its original size when the genomic
DNA was digested with a single-cleavage restriction enzyme,
indicating that this plasmid was not integrated into the genome of
P. falciparum (Method S3). We additionally performed two
independent similar experiments, but did not observe any
Figure 4. Stable Maintenance of pFCEN in the Parasites. (A) The GFP expression of the parasites transfected with pFCEN and pCon were
monitored in the presence of the selective drug (upper panel) and at 8 days after the removal of the drug. The nuclei of the parasites were stained
with Hoechst-33258. The scale bars indicate 10 mm. (B) The percentages of GFP-positive parasites in the absence of the drug were calculated as
described in the Materials and Methods. The red and blue lines indicate the percentage of GFP-positive parasites transfected with pFCEN and pCon,
respectively.
doi:10.1371/journal.pone.0033326.g004
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the parasites (data not shown). Therefore, these results clearly
showed that the pFCENv2 can be maintained as an episomal
plasmid as well as the pFCEN. Because similar suppression of
homologous recombination was observed with the centromere
plasmid of P. berghei in which the recombination is more readily
occurred than in P. falciparum, the recombination between the
centromere plasmid and the genomic DNA of P. falciparum might
be suppressed by the function of pfcen5-1.5.
In P. falciparum, plasmids replicate by a rolling circular
mechanism and ultimately form large concatemeric multimers
[5,6]. To investigate whether pFCEN formed concatemers,
Southern analysis was performed using the gfp gene as a target.
Undigested genomic DNA was isolated from parasites maintained
for over two months under drug selection. In this analysis, only
two signals were detected at larger (18.0 kb) and smaller (5.5 kb)
sizes than that of pFCEN (8.0 kb), suggesting that these two signals
were from the open circular and the super-coiled forms of pFCEN,
respectively (Figure 5B). In contrast to pFCEN, a strong signal was
detected at more than 50 kb in the undigested genomic DNA from
parasites carrying pCon (Figure 5B), indicating the formation of
large concatemers, as described above. Similar Southern analysis
of the control parasite showed that the size of the strong signal
(concatemers) shifted to a smaller size when the genomic DNA was
digested with BamHI, which is a restriction enzyme that cleaves
once in the pCon sequence. The detected signal size was consistent
with that of pCon; thus, the high copy number was caused by the
formation of large concatemers. Therefore, all of these results
indicate that pfcen5-1.5 suppressed replication via the rolling
circular mechanism.
Discussion
In this study, we developed a centromere plasmid, pFCEN, for
P. falciparum by incorporating a shortened centromere, pfcen5-1.5,
into the plasmid DNA. The pFCEN plasmid segregated into
daughter cells with approximately 99% efficiency during cell
division and, thus, was stably maintained in the parasites without
any drug-mediated selective pressure. These results clearly
demonstrate that pfcen5-1.5 functioned as a centromere in P.
falciparum.
The sequence analysis of the centromeres of Plasmodium spp.
suggested that they have the following common sequence features:
they consist of repetitive and non-repetitive regions, and the
repetitive region is located at the one end of the centromere. This
analysis further suggested that the length of the repetitive regions
was conserved during evolution but that the length of the non-
repetitive regions was not. In addition, our previous results showed
that the repetitive or non-repetitive regions alone did not fully
function in the rodent malaria parasite P. berghei [12], indicating
that both regions are required for the function of the centromere
in these parasites. Taken all together, we speculate that the
centromere could function properly in P. falciparum as long as it
retained the combination of the full-length repetitive region and a
portion of the non-repetitive region. Indeed, our present results
showed that the small centromere pfcen5-1.5, which consists of the
original repetitive region and a truncated non-repetitive region,
functioned as a centromere in the parasites, supporting the above
hypothesis. The centromeres of eukaryotes generally form
centromere-specific nucleosomes, which includes the histone H3
variant, CENP-A. This centromere-specific nucleosome provides
the structural basis for the assembly of the kinetochore proteins
[17]. Recent reports on Saccharomyces cerevisiae and humans further
showed that the specific chaperones, Scm3 and HUJRP,
respectively, mediate the loading of CENP-A at the centromere
[18,19]. Therefore, we hypothesized that those sequence features
might provide the signal for the recruitment of the centromere-
specific chaperone to the centromere in P. falciparum. Based on
those common sequence features, it will be possible to design
centromeres for other Plasmodium spp., and similar centromere
plasmids will be developed for those parasites.
The genome of P. falciparum has been elucidated, and the
functional analysis of the genes of this organism is a major tool for
Figure 5. Southern Analysis of pFCEN in the Parasites. (A) To
determine the copy number of pCon (lane a) and pFCEN (lane b),
Southern analyses were performed by using two probe DNAs, the gfp
and pfsir2A genes. The gfp and pfsir2A probes recognised the plasmids
and the single, endogenous genomic pfsir2A copy, respectively. In this
analysis, the signal from the pfsir2A gene was used as the internal
control. The copy number of each plasmid was determined by
comparing the signal intensities of the plasmids with that of the
internal control. The asterisks mark three unexpected signals found in
the genomic DNA including pCon. In contrast, corresponding signals
were not detected in the genomic DNA including pFCEN. Therefore,
these signals likely result from various derivatives, which might be
irregularly generated from pCon during the replication, suggesting that
pfcen5-1.5 ensured the accurate replication of the plasmid. (B) The
parasites transfected with the pFCEN and the pCon plasmids were
maintained in the presence of the drug for 2 months, and their genomic
DNA, including the plasmids, were purified. Southern analysis of both
plasmids in the parasites was performed using purified genomic DNA
and the gfp gene as a probe DNA. In this analysis, the undigested
genomic DNA (lane a, pCon, and lane c, pFCEN) and the BamHI-
digested DNA (lane b, pCon, and lane d, pFCEN) were used. The arrows
indicate the BamHI-digested pFCEN and pCon. The upper and lower
triangles indicate the closed circular and the super-coiled forms of
pFCEN, respectively. Asterisks indicate concatemers of pCon that were
detected in the undigested genomic DNA containing pCon.
doi:10.1371/journal.pone.0033326.g005
Centromere Plasmid for Plasmodium falciparum
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e33326understanding its biology and for the identification of drug targets
and vaccine candidates. However, the function of many P.
falciparum genes remains unclear. One of the reasons for this must
be that the technology for the genetic modification of P. falciparum
is still poor. As described in the Introduction, the gene transfer
techniques for this parasite have several problems, such as a low
transfection efficiency, the instability of the transgene in the
parasite, and the increase in its copy number. In contrast, the
pFCEN plasmid demonstrated the following technical advantages
through the function of pfcen5-1.5. First, transgenic parasites can
be quickly generated using pFCEN because of the efficient
segregation in this parasite. Second, pFCEN is maintained as a
single copy in the parasites as a result of its precise replication.
Third, pFCEN is not integrated into the genome over multiple
rounds of DNA replications and is constantly maintained as
extrachromosomal DNA. These advantages will allow the
improvement of the gene transfer technique for P. falciparum, and
thus, the pFCEN5 plasmid promises to be a standard tool for the
molecular genetic study of P. falciparum. On the other hand, the
pFCEN cannot be utilized for the genome modifications of P.
falciparum, because the homologous recombination might be
suppressed by the function of the centromere. Thus the pFCEN
is not suitable for the gene-knock out and the gene-knock in
experiments.
P. falciparum develops unusual organelles, which are called the
rhoptry and the microneme, and secretes the proteins that are
stored in these organelles when the parasites invade host cells [20].
In addition, this parasite expresses its own proteins on the cell
surface and in the cytoplasm of the host cells and utilises these
proteins for the evasion of the host immune response and for the
interaction with host proteins [21]. Thus, the function of these
genes could be predicted based on the localisation of its product in
P. falciparum. Currently, to investigate the localisation of the gene
products in these parasites, fluorescence marker proteins, such as
GFP and RFP, have been fused to the N- or C-terminus of the
gene products by homologous recombination. However, this
approach takes several months to generate the desired transgenic
parasites because of the low recombination frequency. Further-
more, when these fusion proteins are expressed, high amounts of
the recombinant proteins are expressed in the parasites because of
the high copy number, resulting in their mislocalisation, as a
portion of these proteins are left in the cytoplasm without being
sorted. In contrast to these approaches, gene products may be
easily fused to fluorescent proteins using pFCEN. As shown in this
study, transgenic parasites that express fluorescence-tagged
proteins may be generated within two weeks using pFCEN. In
addition, the expression level of the recombinant fusion protein
should be similar to that of the endogenous gene product because
of the single-copy nature of the plasmid. Thus, pFCEN will be
useful for the localisation analysis of proteins in P. falciparum.
The elucidation of transcriptional regulation mechanisms is
important for understanding the biology of P. falciparum. Stage-
specific transcription factors were recently identified in both
human and rodent malaria parasites, providing clues to the
transcriptional regulation mechanisms of Plasmodium spp.
[22,23,24,25,26]. In vivo evaluation of the transcriptional activities
of specific promoters is also necessary for studying the transcrip-
tional regulation of the parasite. In addition, serial site-specific
mutations and deletions in those regulatory sequences will allow
for the identification of the cis-acting elements. However, the
promoters on conventional plasmids (e.g., pCon) possess an
apparent high activity because of their high copy number, and
thus, it would be difficult to use these plasmids for such gene
expression profiling. Moreover, a significant amount of time and
effort would be required to generate transgenic parasites carrying
serial site-specific mutations and deletions by homologous
recombination. Because pFCEN is maintained as a single-copy
plasmid in the parasites, transcription from its promoter should be
similar to the endogenous expression with regard to the timing and
activity level. In addition, transgenic parasites can be generated
more quickly using pFCEN than using homologous recombina-
tion, allowing the high-throughput analysis of cis-acting elements.
Therefore, we propose that pFCEN will be the best tool for
profiling gene expression in P. falciparum.
We showed that the shortened form of the centromere
functioned properly in P. falciparum and that the centromere
plasmid pFCEN can be utilised as a new genetic tool for the study
of this parasite. Because the centromeres of Plasmodium spp. exhibit
a common sequence structure, similar centromere plasmids can be
constructed for other species, such as P. vivax, for which genetic
modification technologies have been under development. In
addition, a linear form of the artificial chromosome for P.
falciparum can be developed by incorporating the telomere
sequence into pFCEN. Such an artificial chromosome will be a
useful tool for epigenetic studies and chromosome biology research
focused on this parasite.
Materials and Methods
Sequence analysis of the Centromere of Plasmodium spp
The sequences of the predicted centromeres of chromosomes 1
through 9, 12 and 13 of P. falciparum were obtained from the public
database PlasmoDB (http://plasmodb.org). The centromeres of
chromosome 11 and 14 of P. falciparum were predicted based on
their A/T contents. Briefly, the entire genomic sequences of both
chromosomes were scanned with regard to the A/T content using
Artemis 11 with a window size of 120 bp (http://www.sanger.ac.
uk/resources/software/artemis/) and highly A/T-rich regions
(.95.0%) were identified as putative centromeres. The centro-
meres of P. vivax and P. berghei were predicted based on the
genomic synteny conserved between Plasmodium spp. First, the
orthologues of genes up-stream and down-stream of the
centromere of P. falciparum were identified by searching by
sequence similarity, and the sequences of the genomic regions
between the up-stream and down-stream orthologous genes were
then obtained. Next, the highly A/T-rich regions in the obtained
genomic sequences were identified in a similar manner as
described above and then predicted to be the putative centromeres
of P. vivax and P. berghei. The sequences of the centromeres from
chromosome 5 (DQ054838.1) and 13 (DQ054839.1) of P. yoelii
were obtained from GenBank (www.ncbi.nlm.nih.gov/sites/
entrez?db=nucleotide). To identify the repetitive regions within
all of the centromeres, dot matrix analysis was conducted using
Dotlet (http://myhits.isb-sib.ch/cgi-bin/dotlet) with a window size
of 15 bp. In these analyses, the sequence identities were only
recorded when they were greater than 80% in the window. The
presence and locations of sequence elements in each repetitive
region were identified using the Tandem Repeats Finder program
(http://tandem.bu.edu/trf/trf.html). The sequences and arrange-
ments of any repetitive regions within the centromere were
characterised using the default settings.
Construction of the Centromere Plasmid
The DNA fragment containing the shortened centromere of
chromosome 5 of the 3D7 strain of P. falciparum was amplified by
two steps of PCR. The primary PCR was performed using the
primer pair P1: 59-GCAATAACATAATAATAGATCAATA-
TAAC-39 and P2: 59-ATTAAATAATAATAACAAACGGGA-
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secondary PCR was performed using the purified product as the
template DNA and the primer pair P3: 59-AAAGGATCCTA-
TAATAATTTATGTATAATTAAATTAAATATTATAAAC A-
CAC-39 and P4: 59-AAAGCGGCCGCAATTAAATATTATT-
TAATTATTAATATATTAATTATTTAGAC-39. The obtained
final PCR product was digested with BamHI and NotI and then
cloned into the plasmid vector containing the human dihydrofo-
late reductase (hdhfr) gene and the gfp gene, the products of which
served as a drug-selectable marker and a fluorescence marker,
respectively. The transcription of both genes was controlled under
the dual-driven eef1-a promoter of P. berghei. The resulting plasmid
was named pFCEN and was used as the centromere plasmid.
Cultivation and Synchronisation of the Parasite
The Plasmodium falciparum 3D7 strain was obtained from the
Malaria Research and Reference Reagent Resource Center
(http://www.mr4.org/). The obtained parasites were cultivated
with human red blood cells (RBCs: type O blood, Ht 2%, the
Japanese red cross aichi blood centre) in complete medium, which
consisted of RPMI-1640, containing 10% human serum (the
Japanese red cross aichi blood centre), 10% AlbuMAX I (GIBCO
BRL), 25 mM HEPES, 0.225% sodium bicarbonate, and
0.38 mM hypoxanthine supplemented with 10 mg/ml gentamicin,
and were incubated under low-oxygen conditions (90% N2,5 %
CO2, and 5% O2). When the parasitemia had reached
approximately 5%, the infected RBCs were transferred to freshly
prepared RBCs. The parasites were synchronised using 5% D-
sorbitol according to a standard protocol [27]. Briefly, infected
RBCs were quickly suspended in 10 volumes of 5% D-sorbitol and
then incubated exactly at 37uC for 8 min. After the incubation, the
parasites were collected by centrifugation, washed with incomplete
medium (RPMI-1640 containing 25 mM HEPES, 0.225% sodium
bicarbonate, and 0.38 mM hypoxanthine supplemented with
10 mg/ml gentamicin) and cultivated in complete medium, as
described above.
Transfection of Parasites with the Centromere plasmid
Using DNA-Loaded RBCs
The transfection of the parasites was performed by the invasion
of DNA-loaded erythrocytes [28]. Briefly, RBCs were washed
three times with incomplete medium and resuspended to 50%
hematocrit. The pFCEN and the pCon plasmids were purified
using the QIAGEN miniprep kit (QIAGEN), precipitated with
ethanol, and dissolved in incomplete cytomix (120 mM KCl,
0.15 mM CaCl2, 2 mM EGTA, 5 mM MgCl2,1 0m MK 2HPO4/
KH2PO4, 25 mM HEPES, pH 7.6). The washed RBCs and
12.5 mg of the DNA samples were combined in an ice-cold cuvette
and then electroporated using a Bio-Rad Gene Pulser II at
0.31 kV and 950 mF. The DNA-loaded RBCs were immediately
washed three times with complete medium and then infected with
the parasites. The medium was changed every 24 hours, and the
drug selection of the transgenic parasites using pyrimethamine
(2.5 ng/ml) was initiated 4 days after the electroporation.
Assay to Determine the Maintenance of the Centromere
Plasmid in the Parasites
Transfected parasites were preliminary maintained for a period
of 7 days in complete medium supplemented with pyrimethamine
(2.5 ng/ml) to ensure that all of the parasites retained the
introduced plasmids. After this period, the parasites were
synchronised using 5% D-sorbitol, as described above, and then
cultured in complete medium with fresh RBCs in the absence and
the presence of pyrimethamine. Because the transcriptional
activity of the eef1-a promoter is maximal in the parasites at the
schizont stage, the GFP expression in was monitored by
fluorescence microscopy at this developmental stage, that is, every
48 hours, after staining with Hoechst-33258 (10 mM final
concentration). Similar monitoring was conducted using flow
cytometry (LSR Fortessa cell analyser, BD Science). Some of the
parasites died spontaneously during the in vitro culture, and to
account for its effect, the percentage of the GFP-positive parasites
in the absence of selection was expressed as a relative value, setting
the percentage in the presence of the drug to 100%. Triplicate
experiments were performed for each transfected parasite. Based
on the percentage of the GFP-positive parasites after the removal
of pyrimethamine, the segregation efficiency of the plasmid per
nuclear division was calculated according to the following
equation:
Seff~ Pgfp=100
 1=n,
where Seff and Pgfp are the segregation efficiency and the
percentage of GFP-positive parasites, respectively, and n is the
number of nuclear divisions. In this study, we assumed that 5
rounds of nuclear division occurred during one blood-stage
schizogony of 48 hours. We determined the segregation efficien-
cies of pFCEN and pCon at days 6 and 8 after the removal of drug
selection and then calculated their averages.
Southern Analysis of the Centromere Plasmid in the
Parasites
The parasites transfected with pFCEN or pCon were main-
tained in the presence of pyrimethamine for 1 month and used for
the extraction of genomic DNA. The parasite genomic DNA
containing the plasmids was digested with NheI, which cleaved a
single site, and blotted onto a membrane. In this Southern
hybridisation, we simultaneously used both the gfp and pf-sir2A
genes (PF13_0152) as probe DNAs. The pf-sir2A genes specifically
hybridised with the parasite genome and, thus, were used as an
internal control to determine the copy number of the plasmid. The
signal intensities were quantified using Quantity One software
(BioRad). The copy number of the pFCEN plasmid was estimated
by comparing the intensity of the signal from the pFCEN plasmid
with that from the parasite genome.
To determine whether the plasmids formed concatemers in the
parasites over long culture periods, the parasites were maintained
under drug selection for 2 months, and their genomic DNA,
including the plasmids, was used for the Southern analysis.
Undigested genomic DNA and BamHI-digested genomic DNA
were transferred to the membrane, and the plasmids were detected
by hybridising with the gfp gene used in the above analysis.
Supporting Information
Method S1 Growth of transgenic parasites in the presence and
absence of the selective drug.
(DOC)
Method S2 Construction of pFCENv2 and the generation of the
transgenic parasites carrying pFCEN5v2.
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Method S3 Southern analysis of pFCENv2 in the parasites.
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Figure S1 Dot matrix analyses of the centromere of two rodent
malaria parasites, P. berghei and P. yoelii, were performed using the
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somes 5 and 13 of each parasite were used. The panels depict the
graphical results of the matrix analysis of one centromere aligned
against the other centromere in the corresponding chromosomes.
The diagonal line within each analysis represents the sequence
identity between the two centromeres from P. berghei and P. yoelii.
The triangles indicate the repetitive region in each centromere.
The truncated regions in the non-repetitive region of the
centromeres from chromosomes 5 and 13 of P. yoelii were
predicted, as shown by the white boxes.
(EPS)
Figure S2 The growth of the parasites carrying pFCEN and
pCon were monitored in the presence and absence of pyrimeth-
amine. The open and closed circles indicate the parasitemia of the
parasites carrying pFCEN and pCon, respectively. The blue and
red lines show the conditions in the presence and the absence of
the drug, respectively.
(EPS)
Figure S3 (A) The pFCENv2 plasmid is 8477 bp, and pfcen5-1.5
is placed downstream of the 39 UTR of the hrp2 gene of P.
falciparum. In this plasmid, blasticidin S deaminase is used as the
drug-selectable marker. (B) The parasites carrying pFCENv2
(lanes a and b) were maintained in the presence of the drug for 2
months, and genomic DNA was purified. Southern analysis of
pFCENv2 was performed using the gfp gene as a probe. The
arrows indicate the signals of pFCENv2. Their sizes are consistent
with that of pFCENv2, indicating that the plasmid did not
integrate into the parasite genome during long-term culture. (C)
To determine the copy numbers of pConv2 (lane a) and pFCENv2
(lane b and c) in the parasites, Southern analyses were performed
using the 39UTR of the hrp2 gene of P. falciparum as a probe. The
copy number of each plasmid was determined by comparing the
signal intensities of the plasmids with that of the internal control.
The copy numbers of pFCENv2 and pConv2 were estimated to be
1.1 and 3.9, respectively. The arrows indicate the signals from
each plasmid and the genomic DNA of the parasites.
(EPS)
Table S1 Sequence properties of centromeres of Plasmodium spp
including P. falciparum, P. vivax, P. berghei and P. yoelii are
summarized.
(XLSX)
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